STRUCTURE-ACTIVITY-RELATIONSHIPS OF 8-CYCLOALKYL-1,3-DIPROPYLXANTHINES AS ANTAGONISTS OF ADENOSINE RECEPTORS

被引:32
作者
KATSUSHIMA, T [1 ]
NIEVES, L [1 ]
WELLS, JN [1 ]
机构
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.1021/jm00169a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
8-Substituted xanthines currently represent the most potent class of adenosine-receptor antagonists. A series of 8-substituted 1,3-dipropylxanthines was prepared and their potency as antagonists of A1and A2 adenosine receptors of human platelets and rat adipocytes, respectively, were determined. No agents studied were as potent as 8-cyclopentyl-l,3-dipropylxanthine as antagonists of the A1 adenosine receptor, but 8-(2-methylcyclopropyl)-l,3-dipropylxanthine was at least 1000-fold more potent as an antagonist of A1than of A2 adenosine receptors. While most substitutions on the 8-cycloalkyl moiety caused decreased potency to inhibit both A1and A2 adenosine receptors, 8-[trans-4-(acetamidomethyl)cyclohexyl]-l,3-dipropylxanthine was nearly equipotent as an antagonist of the two receptors and appeared to be the most potent antagonist of A2 adenosine receptors reported to date. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:1906 / 1910
页数:5
相关论文
共 24 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   ADENOSINE RECEPTOR-BINDING - STRUCTURE-ACTIVITY ANALYSIS GENERATES EXTREMELY POTENT XANTHINE ANTAGONISTS [J].
BRUNS, RF ;
DALY, JW ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (07) :2077-2080
[3]   PD 115,199 - AN ANTAGONIST LIGAND FOR ADENOSINE A2-RECEPTORS [J].
BRUNS, RF ;
FERGUS, JH ;
BADGER, EW ;
BRISTOL, JA ;
SANTAY, LA ;
HAYS, SJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (01) :64-69
[4]   1,3-DIALKYL-8-(PARA-SULFOPHENYL)XANTHINES - POTENT WATER-SOLUBLE ANTAGONISTS FOR A1-ADENOSINE AND A2-ADENOSINE RECEPTORS [J].
DALY, JW ;
PADGETT, W ;
SHAMIM, MT ;
BUTTSLAMB, P ;
WATERS, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (04) :487-492
[5]  
FERBER E, 1943, CHEM BER, V76, P1019
[6]   SYNTHESIS OF XANTHINES AS ADENOSINE ANTAGONISTS, A PRACTICAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP APPLICATION [J].
HAMILTON, HW ;
ORTWINE, DF ;
WORTH, DF ;
BADGER, EW ;
BRISTOL, JA ;
BRUNS, RF ;
HALEEN, SJ ;
STEFFEN, RP .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (08) :1071-1079
[7]   8-SUBSTITUTED XANTHINES AS ANTAGONISTS AT A1-ADENOSINE AND A2-ADENOSINE RECEPTORS [J].
JACOBSON, KA ;
DELACRUZ, R ;
SCHULICK, R ;
KIRIASIS, L ;
PADGETT, W ;
PFLEIDERER, W ;
KIRK, KL ;
NEUMEYER, JL ;
DALY, JW .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (19) :3653-3661
[8]  
JOHNSON RA, 1989, MOL PHARMACOL, V35, P681
[9]  
KONO T, 1975, J BIOL CHEM, V250, P7826
[10]   SELECTIVE-INHIBITION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES BY ANALOGS OF 1-METHYL-3-ISOBUTYLXANTHINE [J].
KRAMER, GL ;
GARST, JE ;
MITCHEL, SS ;
WELLS, JN .
BIOCHEMISTRY, 1977, 16 (15) :3316-3321